Tech Company Financing Transactions

Menlo Therapeutics Funding Round

Menlo Therapeutics, based in Redwood City, secured $50 million from venBio, Aisling Capital and Bay City Capital.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series C
Proceeds Purpose
This funding round follows the successful completion of two phase 2 clinical trials: TCP-101 evaluated subjects with chronic pruritus from multiple underlying causes, and TCP-102 studied subjects with chronic pruritus associated with prurigo nodularis.

Company Information

Company Status
Private & Independent
Mailing Address
200 Cardinal Way 2nd Floor
Redwood City, CA 94063
Email Address
Menlo Therapeutics Inc. is a clinical stage pharmaceutical company dedicated to the development of serlopitant, a once-daily oral NK-1 receptor antagonist, for the treatment of chronic pruritus and chronic cough.
Menlo Therapeutics LinkedIn Company Profile
Social Media
Menlo Therapeutics Company Twitter Account
Company News
Menlo Therapeutics News
Menlo Therapeutics on Facebook
Menlo Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
David Domzalski
  David Domzalski LinkedIn Profile  David Domzalski Twitter Account  David Domzalski News  David Domzalski on Facebook
Chief Financial Officer
Andrew Saik
  Andrew Saik LinkedIn Profile  Andrew Saik Twitter Account  Andrew Saik News  Andrew Saik on Facebook
Chief Scientific Officer
Iain Stuart
  Iain Stuart LinkedIn Profile  Iain Stuart Twitter Account  Iain Stuart News  Iain Stuart on Facebook
Vice President
Russell Elliott
  Russell Elliott LinkedIn Profile  Russell Elliott Twitter Account  Russell Elliott News  Russell Elliott on Facebook
VP - Bus. Development
Matthew Wiley
  Matthew Wiley LinkedIn Profile  Matthew Wiley Twitter Account  Matthew Wiley News  Matthew Wiley on Facebook
VP - General Counsel
Mutya Harsch
  Mutya Harsch LinkedIn Profile  Mutya Harsch Twitter Account  Mutya Harsch News  Mutya Harsch on Facebook
VP - Human Resources
Ray Steitz
  Ray Steitz LinkedIn Profile  Ray Steitz Twitter Account  Ray Steitz News  Ray Steitz on Facebook



Browse more venture capital transactions:

Prev: 7/19/2017: Alation venture capital transaction
Next: 7/19/2017: ObEN venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary